CXCR4 and breast cancer: The metastatic phenotype implies multiple changes; in particular co-expression of CXCR4, VEGF-A and MMP-9 is strongly correlated with lymph node metastasis and is a prognostic marker of the metastatic ability of primary breast cancer [26].